AngioDynamic International Life Symposium March 30 – April 1
March 28, 2023
Lu Alleruzzo, CEO & Co-Founder; and Tomas Hode, PhD, Co-Founder, CIO, & President were delighted to receive an invitation to…
Immunophotonics Presenting at BIO CEO & Investor Conference February 6 – 9, 2023
February 1, 2023
Immunophotonics, Inc. is grateful to NCI (the National Cancer Institute of NIH) and its SBIR Investor Initiatives Team for sponsoring…
Immunophotonics Announces 1st Patient Dosed in IP-IIO-622 Phase 1b/2a Clinical Trial in Advanced Solid Tumor Indications
January 26, 2023
Immunophotonics, Inc. announced the initiation of recruitment and the dosing of its first patient in a clinical trial assessing safety…
SIO Annual Scientific Meeting, January 19 – 23, 2023
January 16, 2023
Tomas Hode, PhD, Co-Founder, CIO, and President at @Immunophotonics, Inc. will be attending the Society of Interventional Oncology (SIO) 2023…
Poster Presented at the ESMO Immuno-Oncology Congress
January 11, 2023
A poster summarizing the results of the Phase 1b portion of the study SAKK 66/17 concerning the combination of thermal…
JPM 2023 San Francisco, January 9 – 12, 2023
December 28, 2022
Our networking is well underway for the JPM 2023. Attending the annual summit Lu Alleruzzo at JPM Healthcare Conference, Theresa…
Immunophotonics, Inc. was recently named one of six awardees in Johnson & Johnson’s Innovations for Vets: Lung Cancer and Physical Trauma QuickFire Challenge.
December 20, 2022
We are grateful to Johnson & Johnson Innovation for funding this vital work and are honored to advance medicine for…
Florida Venture Summit
December 7, 2022
Immunophotonics, Inc is proud to have been selected by YoungStartup Ventures to present at the Florida Venture Summit in Miami…
Wei Chen’s Paper Publication in the Journal for ImmunoTherapy of Cancer (JITC)
November 8, 2022
Congratulations to Professor Wei Chen and his lab at the University of Oklahoma for their publication in one of the…
Immunophotonics Co-Founder Wei Chen, Ph.D. Awarded $2.5 Million Grant by the National Cancer Institute
October 31, 2022
Immunophotonics, Inc. would like to congratulate Wei Chen, Ph.D. on his recently awarded Grant by the National Cancer Institute of…